Adding VR-Based Episodic Future Thinking Training to Executive- Function Training for Children With ADHD: A Randomized Controlled Trial (Virtual Realit)

May 15, 2026 updated by: Qilu Hospital of Shandong University
This study recruited 80 children aged 5-12 with clinically diagnosed ADHD from Qilu Hospital, Shandong University, and randomly divided them into two groups with 40 children in each group: the EF-only group and the EF+VR-EFT group. Both groups received a 2-week intervention with 5 sessions per week

Study Overview

Detailed Description

This study recruited 80 children aged 5-12 with clinically diagnosed ADHD from Qilu Hospital, Shandong University, and randomly divided them into two groups with 40 children in each group: the EF-only group and the EF+VR-EFT group. Both groups received a 2-week intervention with 5 sessions per week

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shandong
      • Jinan, Shandong, China
        • Qilu Hospital of Shandong University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 5-12 years with a clinical diagnosis of ADHD confirmed by a multidisciplinary clinical team according to DSM-5 criteria.
  • Normal intellectual functioning.
  • Absence of major neurological or medical disorders.

Exclusion Criteria:

  • Participants with incomplete or missing questionnaire data (8 cases were excluded based on this criterion in the study).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: executive function
All participants received 2 weeks of conventional executive function (EF) training (6 sessions per week). After the intervention, their executive function improved slightly, with small changes in higher-order processes such as inhibitory control and metacognition.

Control Group (EF-only group): Participants received a 2-week standardized, non-immersive conventional executive function (EF) training, with 6 sessions per week (45 minutes per session) under researcher supervision, targeting core executive processes such as inhibitory control and working memory.

Experimental Group (EF+VR-EFT group): On the basis of the same conventional EF training as the control group, participants additionally completed a 20-minute VR-based episodic future thinking (VR-EFT) module per session, delivered via PICO headsets through immersive gameplay in a controlled clinical setting.

Experimental: EF+VR-EFT
Experimental Group (EF+VR-EFT group): On the basis of the same conventional EF training as the control group, participants additionally completed a 20-minute VR-based episodic future thinking (VR-EFT) module per session, delivered via PICO headsets through immersive gameplay in a controlled clinical setting.
Experimental Group (EF+VR-EFT group): On the basis of the same 2-week conventional EF training, participants additionally completed a VR-based episodic future thinking (VR-EFT) module in each session. Their executive function achieved more significant and stable improvements, particularly in higher-order domains.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BRIEF score
Time Frame: two weeks
The main outcome measures of the study were assessed via the BRIEFfocusing on executive function changes after the 2-week intervention,BRIEF-assessed executive function changes, with specific difficulty score reductions in inhibition and metacognition
two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2024

Primary Completion (Actual)

December 1, 2025

Study Completion (Actual)

December 30, 2025

Study Registration Dates

First Submitted

March 17, 2026

First Submitted That Met QC Criteria

May 15, 2026

First Posted (Actual)

May 18, 2026

Study Record Updates

Last Update Posted (Actual)

May 18, 2026

Last Update Submitted That Met QC Criteria

May 15, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ADHD

Clinical Trials on executive function

Subscribe